Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shih-Cheng Yang

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Hepatology International|July 24, 2015
The effect of systemic antibiotic prophylaxis for cirrhotic patients with peptic ulcer bleeding after endoscopic interventionsShih-Cheng Yang, Keng-Liang Wu, Jing-Hung Wang, et al.
Biomedical Journal|March 16, 2022
The efficacies of non-bismuth containing quadruple therapies in the treatment of first-line anti-Helicobacter pylori across 4-year time interval with changing antibiotics resistanceTzu-Hsin Huang, Shih-Cheng Yang, Wei-Chen Tai, et al.
Infection and Drug Resistance|June 27, 2019
First-line <i>Helicobacter pylori</i> eradication rates are significantly lower in patients with than those without type 2 diabetes mellitusChih-Chien Yao, Chung-Mou Kuo, Chien-Ning Hsu, et al.
The Journal of Antimicrobial Chemotherapy|February 16, 2019
A 14 day esomeprazole- and amoxicillin-containing high-dose dual therapy regimen achieves a high eradication rate as first-line anti-Helicobacter pylori treatment in Taiwan: a prospective randomized trialWei-Chen Tai, Chih-Ming Liang, Chung-Mou Kuo, et al.
International Journal of Environmental Research and Public Health|November 30, 2018
Treatment and Cost of Hepatocellular Carcinoma: A Population-Based Cohort Study in TaiwanSeng-Howe Nguang, Cheng-Kun Wu, Chih-Ming Liang, et al.
Plos One|October 21, 2016
The Association of Helicobacter pylori Eradication with the Occurrences of Chronic Kidney Diseases in Patients with Peptic Ulcer DiseasesJiunn-Wei Wang, Chien-Ning Hsu, Wei-Chen Tai, et al.
Drug Design, Development and Therapy|May 24, 2019
Clinical efficacy of 60-mg dexlansoprazole and 40-mg esomeprazole after 24 weeks for the on-demand treatment of gastroesophageal reflux disease grades A and B: a prospective randomized trialHung-Hsien Chiang, Deng-Chyang Wu, Pin-I Hsu, et al.
Plos One|May 11, 2018
Multiple bacterial infections increase the risk of hepatic encephalopathy in patients with cirrhosisLan-Ting Yuan, Seng-Kee Chuah, Shih-Cheng Yang, et al.
Plos One|January 13, 2017
Risk of Rebleeding and Mortality in Cirrhotic Patients with Peptic Ulcer Bleeding: A 12-Year Nationwide Cohort StudyShih-Cheng Yang, Chien-Ning Hsu, Chih-Ming Liang, et al.
Plos One|January 25, 2017
The Role of Adjuvant Acid Suppression on the Outcomes of Bleeding Esophageal Varices after Endoscopic Variceal LigationCheng-Kun Wu, Chih-Ming Liang, Chien-Ning Hsu, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Hepatology International|July 24, 2015
The effect of systemic antibiotic prophylaxis for cirrhotic patients with peptic ulcer bleeding after endoscopic interventionsShih-Cheng Yang, Keng-Liang Wu, Jing-Hung Wang, et al.
Biomedical Journal|March 16, 2022
The efficacies of non-bismuth containing quadruple therapies in the treatment of first-line anti-Helicobacter pylori across 4-year time interval with changing antibiotics resistanceTzu-Hsin Huang, Shih-Cheng Yang, Wei-Chen Tai, et al.
Infection and Drug Resistance|June 27, 2019
First-line <i>Helicobacter pylori</i> eradication rates are significantly lower in patients with than those without type 2 diabetes mellitusChih-Chien Yao, Chung-Mou Kuo, Chien-Ning Hsu, et al.
The Journal of Antimicrobial Chemotherapy|February 16, 2019
A 14 day esomeprazole- and amoxicillin-containing high-dose dual therapy regimen achieves a high eradication rate as first-line anti-Helicobacter pylori treatment in Taiwan: a prospective randomized trialWei-Chen Tai, Chih-Ming Liang, Chung-Mou Kuo, et al.
International Journal of Environmental Research and Public Health|November 30, 2018
Treatment and Cost of Hepatocellular Carcinoma: A Population-Based Cohort Study in TaiwanSeng-Howe Nguang, Cheng-Kun Wu, Chih-Ming Liang, et al.
Plos One|October 21, 2016
The Association of Helicobacter pylori Eradication with the Occurrences of Chronic Kidney Diseases in Patients with Peptic Ulcer DiseasesJiunn-Wei Wang, Chien-Ning Hsu, Wei-Chen Tai, et al.
Drug Design, Development and Therapy|May 24, 2019
Clinical efficacy of 60-mg dexlansoprazole and 40-mg esomeprazole after 24 weeks for the on-demand treatment of gastroesophageal reflux disease grades A and B: a prospective randomized trialHung-Hsien Chiang, Deng-Chyang Wu, Pin-I Hsu, et al.
Plos One|May 11, 2018
Multiple bacterial infections increase the risk of hepatic encephalopathy in patients with cirrhosisLan-Ting Yuan, Seng-Kee Chuah, Shih-Cheng Yang, et al.
Plos One|January 13, 2017
Risk of Rebleeding and Mortality in Cirrhotic Patients with Peptic Ulcer Bleeding: A 12-Year Nationwide Cohort StudyShih-Cheng Yang, Chien-Ning Hsu, Chih-Ming Liang, et al.
Plos One|January 25, 2017
The Role of Adjuvant Acid Suppression on the Outcomes of Bleeding Esophageal Varices after Endoscopic Variceal LigationCheng-Kun Wu, Chih-Ming Liang, Chien-Ning Hsu, et al.
Pageof 4